First Topical Therapy for Facial Angiofibroma Nabs FDA Approval

(MedPage Today) -- The FDA approved sirolimus 0.2% gel (Hyftor) as the first topical treatment for facial angiofibroma associated with tuberous sclerosis complex (TSC), Nobelpharma announced. The approved indication includes patients 6 years or...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news